Targeted Immune Intervention: How does Eculizumab work?
•
4 min read
Without treatment from complement inhibitors, the 10-year survival rate for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) is just 65% [1.3.3]. Eculizumab revolutionized treatment for this and other rare diseases. But **how does Eculizumab work** to achieve this?
